Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review

Recently, there have been investigations on metformin (Met) as a potential treatment for bone diseases such as osteoporosis, as researchers have outlined that type 2 diabetes mellitus (T2DM) poses an increased risk of fractures. Hence, this systematic review was conducted according to the 2020 PRISM...

Full description

Bibliographic Details
Main Authors: Darren Kin Wai Loh, Amudha Kadirvelu, Narendra Pamidi
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Journal of Clinical Medicine
Subjects:
Online Access:https://www.mdpi.com/2077-0383/11/14/4193
_version_ 1797446159688531968
author Darren Kin Wai Loh
Amudha Kadirvelu
Narendra Pamidi
author_facet Darren Kin Wai Loh
Amudha Kadirvelu
Narendra Pamidi
author_sort Darren Kin Wai Loh
collection DOAJ
description Recently, there have been investigations on metformin (Met) as a potential treatment for bone diseases such as osteoporosis, as researchers have outlined that type 2 diabetes mellitus (T2DM) poses an increased risk of fractures. Hence, this systematic review was conducted according to the 2020 PRISMA guidelines to evaluate the evidence that supports the bone-protective effects of metformin on male animal models with T2DM. Five databases—Google Scholar, PubMed, Wiley Online Library, SCOPUS, and ScienceDirect—were used to search for original randomized controlled trials published in English with relevant keywords. The search identified 18 articles that matched the inclusion criteria and illustrated the effects of Met on bone. This study demonstrates that Met improved bone density and reduced the effects of T2DM on adiposity formation in the animal models. Further research is needed to pinpoint the optimal dosage of Met required to exhibit these therapeutic effects.
first_indexed 2024-03-09T13:36:13Z
format Article
id doaj.art-9b44bc017fb0492e996a89e624b0a07c
institution Directory Open Access Journal
issn 2077-0383
language English
last_indexed 2024-03-09T13:36:13Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Journal of Clinical Medicine
spelling doaj.art-9b44bc017fb0492e996a89e624b0a07c2023-11-30T21:11:38ZengMDPI AGJournal of Clinical Medicine2077-03832022-07-011114419310.3390/jcm11144193Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic ReviewDarren Kin Wai Loh0Amudha Kadirvelu1Narendra Pamidi2Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya 47500, MalaysiaJeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya 47500, MalaysiaJeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya 47500, MalaysiaRecently, there have been investigations on metformin (Met) as a potential treatment for bone diseases such as osteoporosis, as researchers have outlined that type 2 diabetes mellitus (T2DM) poses an increased risk of fractures. Hence, this systematic review was conducted according to the 2020 PRISMA guidelines to evaluate the evidence that supports the bone-protective effects of metformin on male animal models with T2DM. Five databases—Google Scholar, PubMed, Wiley Online Library, SCOPUS, and ScienceDirect—were used to search for original randomized controlled trials published in English with relevant keywords. The search identified 18 articles that matched the inclusion criteria and illustrated the effects of Met on bone. This study demonstrates that Met improved bone density and reduced the effects of T2DM on adiposity formation in the animal models. Further research is needed to pinpoint the optimal dosage of Met required to exhibit these therapeutic effects.https://www.mdpi.com/2077-0383/11/14/4193metformintype 2 diabetesbone densityadiposityanimal
spellingShingle Darren Kin Wai Loh
Amudha Kadirvelu
Narendra Pamidi
Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
Journal of Clinical Medicine
metformin
type 2 diabetes
bone density
adiposity
animal
title Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
title_full Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
title_fullStr Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
title_full_unstemmed Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
title_short Effects of Metformin on Bone Mineral Density and Adiposity-Associated Pathways in Animal Models with Type 2 Diabetes Mellitus: A Systematic Review
title_sort effects of metformin on bone mineral density and adiposity associated pathways in animal models with type 2 diabetes mellitus a systematic review
topic metformin
type 2 diabetes
bone density
adiposity
animal
url https://www.mdpi.com/2077-0383/11/14/4193
work_keys_str_mv AT darrenkinwailoh effectsofmetforminonbonemineraldensityandadiposityassociatedpathwaysinanimalmodelswithtype2diabetesmellitusasystematicreview
AT amudhakadirvelu effectsofmetforminonbonemineraldensityandadiposityassociatedpathwaysinanimalmodelswithtype2diabetesmellitusasystematicreview
AT narendrapamidi effectsofmetforminonbonemineraldensityandadiposityassociatedpathwaysinanimalmodelswithtype2diabetesmellitusasystematicreview